Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells

Molecular tumour targeting has significantly improved anti-cancer protocols. Still, the addition of molecular targeting to the treatment regime has not led to a curative breakthrough. Combined mammalian target of Rapamycin (mTOR) and histone deacetylase (HDAC) inhibition has been shown not only to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Makarević, Jasmina, Tawanaie, Nassim, Juengel, Eva, Reiter, Michael, Mani, Jens, Tsaur, Igor, Bartsch, Georg, Haferkamp, Axel, Blaheta, Roman A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124028/
https://www.ncbi.nlm.nih.gov/pubmed/24779401
http://dx.doi.org/10.1111/jcmm.12299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124028/
https://www.ncbi.nlm.nih.gov/pubmed/24779401
http://dx.doi.org/10.1111/jcmm.12299

Ejemplares similares